Paper33086751
The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease.
Bukke VN and 8 others. Int J Mol Sci, 2020. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease. Papers, record 33086751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33086751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Glucose | Major topic |
| Metabolic Networks and Pathways | Major topic |
| Molecular Targeted Therapy | Major topic |
| Animals | |
| Glycosylation | |
| Humans | |
| Models, Biological |
Source PubMed
References117
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30693278 | Production of Glycopeptide Derivatives for Exploring Substrate Specificity of Human OGA Toward Sugar Moiety. | Front Chem | 2018 | https://conductscience.org/library/papers/30693278 | PubMed |
| 2 | 11788610 | Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11788610 | PubMed |
| 3 | 16412100 | Sialylation enhances the secretion of neurotoxic amyloid-beta peptides. | J Neurochem | 2006 | https://conductscience.org/library/papers/16412100 | PubMed |
| 4 | 30738142 | Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease. | Neurobiol Dis | 2019 | https://conductscience.org/library/papers/30738142 | PubMed |
| 5 | 28465241 | N-glycan and Alzheimer's disease. | Biochim Biophys Acta Gen Subj | 2017 | https://conductscience.org/library/papers/28465241 | PubMed |
| 6 | 15249677 | O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15249677 | PubMed |
| 7 | 29576849 | Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/29576849 | PubMed |
| 8 | 12941958 | Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12941958 | PubMed |
| 9 | 18587388 | A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. | Nat Chem Biol | 2008 | https://conductscience.org/library/papers/18587388 | PubMed |
| 10 | 27570871 | 2016 Alzheimer's disease facts and figures. | Alzheimers Dement | 2016 | https://conductscience.org/library/papers/27570871 | PubMed |
| 11 | 11148210 | Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11148210 | PubMed |
| 12 | 23791707 | γ-Secretase inhibitors and modulators. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23791707 | PubMed |
| 13 | 24409422 | Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. | Clin Transl Imaging | 2013 | https://conductscience.org/library/papers/24409422 | PubMed |
| 14 | 2137449 | Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2137449 | PubMed |
| 15 | 10993067 | Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. | Nature | 2000 | https://conductscience.org/library/papers/10993067 | PubMed |
| 16 | 9497354 | Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9497354 | PubMed |
| 17 | 29460617 | Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway. | ACS Chem Neurosci | 2018 | https://conductscience.org/library/papers/29460617 | PubMed |
| 18 | 17227027 | Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. | J Am Chem Soc | 2007 | https://conductscience.org/library/papers/17227027 | PubMed |
| 19 | 27703002 | Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis. | J Biol Chem | 2016 | https://conductscience.org/library/papers/27703002 | PubMed |
| 20 | 12668248 | Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. | Neurosci Lett | 2003 | https://conductscience.org/library/papers/12668248 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42280440 | Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis. | Nutrients | 2026 | https://conductscience.org/library/papers/42280440 | PubMed |
| 41462898 | Unlocking the Sugar Code: Implications and Consequences of Glycosylation in Alzheimer's Disease and Other Tauopathies. | Biomedicines | 2025 | https://conductscience.org/library/papers/41462898 | PubMed |
| 40903936 | O-GlcNAcylation: A molecular switch linking brain health to neurodegeneration. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/40903936 | PubMed |
| 40336061 | Invasive laser acupuncture targeting muscle: a novel approach to protect dopaminergic neurons and reduce neuroinflammation in a brain of Parkinson's disease model. | Chin Med | 2025 | https://conductscience.org/library/papers/40336061 | PubMed |
| 39765914 | Oxidative Stress, Inflammation and Altered Glucose Metabolism Contribute to the Retinal Phenotype in the Choroideremia Zebrafish. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39765914 | PubMed |
| 38946780 | The alteration and role of glycoconjugates in Alzheimer's disease. | Front Aging Neurosci | 2024 | https://conductscience.org/library/papers/38946780 | PubMed |
| 38516320 | In Silico Localization of Perilymph Proteins Enriched in Meńier̀e Disease Using Mammalian Cochlear Single-cell Transcriptomics. | Otol Neurotol Open | 2023 | https://conductscience.org/library/papers/38516320 | PubMed |
| 37662613 | Agent Orange Causes Metabolic Dysfunction and Molecular Pathology Reminiscent of Alzheimer's Disease. | J Alzheimers Dis Rep | 2023 | https://conductscience.org/library/papers/37662613 | PubMed |
| 37626031 | New insight into protein glycosylation in the development of Alzheimer's disease. | Cell Death Discov | 2023 | https://conductscience.org/library/papers/37626031 | PubMed |
| 37415097 | Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives. | Mol Med | 2023 | https://conductscience.org/library/papers/37415097 | PubMed |
| 36877359 | The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease. | Mol Neurobiol | 2023 | https://conductscience.org/library/papers/36877359 | PubMed |
| 36606272 | Critical appraisal on mitochondrial dysfunction in Alzheimer's disease. | Aging Med (Milton) | 2022 | https://conductscience.org/library/papers/36606272 | PubMed |
| 36408104 | Identification and immune characteristics of molecular subtypes related to protein glycosylation in Alzheimer's disease. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/36408104 | PubMed |
| 35686025 | Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35686025 | PubMed |
| 34916409 | Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injury. | Neural Regen Res | 2022 | https://conductscience.org/library/papers/34916409 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33086751
GET https://conductscience.org/api/papers/v1/33086751/references?page=2